552 related articles for article (PubMed ID: 29797025)
1. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
[TBL] [Abstract][Full Text] [Related]
4. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
5. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
6. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
[TBL] [Abstract][Full Text] [Related]
8. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
9. Oncological and Functional Outcomes of Laparoscopic Radiofrequency Ablation and Partial Nephrectomy for T1a Renal Masses: A Retrospective Single-center 60 Month Follow-up Cohort Study.
Park JM; Yang SW; Shin JH; Na YG; Song KH; Lim JS
Urol J; 2019 Feb; 16(1):44-49. PubMed ID: 30120758
[TBL] [Abstract][Full Text] [Related]
10. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.
Ma Y; Bedir S; Cadeddu JA; Gahan JC
BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553
[TBL] [Abstract][Full Text] [Related]
12. Safety and oncological outcome following radiofrequency ablation of small renal masses in a single center.
Bersang AB; Søndergaard Mosholt KS; Verner Jensen C; Germer U; Holm M; Røder MA
Scand J Urol; 2021 Jun; 55(3):203-208. PubMed ID: 33739218
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes.
De Filippo M; Ziglioli F; Russo U; Pagano P; Brunese L; Bertelli E; Pagnini F; Maestroni U
Radiol Med; 2020 Aug; 125(8):790-797. PubMed ID: 32206984
[TBL] [Abstract][Full Text] [Related]
14. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.
Mayo-Smith WW; Dupuy DE; Parikh PM; Pezzullo JA; Cronan JJ
AJR Am J Roentgenol; 2003 Jun; 180(6):1503-8. PubMed ID: 12760909
[TBL] [Abstract][Full Text] [Related]
15. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M
Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-guided transhepatic radiofrequency ablation of renal tumors: a safe and effective approach.
Hegg RM; Schmit GD; Kurup AN; Weisbrod AJ; Boorjian SA; Atwell TD
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):508-12. PubMed ID: 23934115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
